ENTRABODY Trademark

Trademark Overview


On Wednesday, August 24, 2016, a trademark application was filed for ENTRABODY with the United States Patent and Trademark Office. The USPTO has given the ENTRABODY trademark a serial number of 87150020. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 26, 2024. This trademark is owned by Landing Biotech, Inc.. The ENTRABODY trademark is filed in the Pharmaceutical Products category with the following description:

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases o...
entrabody

General Information


Serial Number87150020
Word MarkENTRABODY
Filing DateWednesday, August 24, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 26, 2024
Registration Number5308014
Registration DateTuesday, October 10, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 10, 2017

Trademark Statements


Goods and ServicesDrug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products for the prevention and treatment of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 26, 2024
Primary Code005
First Use Anywhere DateMonday, December 28, 2015
First Use In Commerce DateMonday, August 1, 2016

Trademark Owner History


Party NameLanding Biotech, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNewton, MA 02466

Party NameLanding Biotech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewton, MA 02466

Party NameLanding Biotech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewton, MA 02466

Trademark Events


Event DateEvent Description
Saturday, August 27, 2016NEW APPLICATION ENTERED
Wednesday, December 21, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 30, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, December 4, 2016ASSIGNED TO EXAMINER
Sunday, December 4, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 17, 2017TEAS STATEMENT OF USE RECEIVED
Friday, August 11, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 11, 2017STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 7, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, September 8, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 10, 2017REGISTERED-PRINCIPAL REGISTER
Monday, October 10, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, April 26, 2024CANCELLED SEC. 8 (6-YR)
Monday, July 17, 2017USE AMENDMENT FILED
Tuesday, January 10, 2017PUBLISHED FOR OPPOSITION
Tuesday, January 10, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, March 8, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT